260 related articles for article (PubMed ID: 35896617)
1. Low lamin A levels enhance confined cell migration and metastatic capacity in breast cancer.
Bell ES; Shah P; Zuela-Sopilniak N; Kim D; Varlet AA; Morival JLP; McGregor AL; Isermann P; Davidson PM; Elacqua JJ; Lakins JN; Vahdat L; Weaver VM; Smolka MB; Span PN; Lammerding J
Oncogene; 2022 Sep; 41(36):4211-4230. PubMed ID: 35896617
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer.
Wazir U; Ahmed MH; Bridger JM; Harvey A; Jiang WG; Sharma AK; Mokbel K
Cell Mol Biol Lett; 2013 Dec; 18(4):595-611. PubMed ID: 24293108
[TBL] [Abstract][Full Text] [Related]
3. Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway.
Kong L; Schäfer G; Bu H; Zhang Y; Zhang Y; Klocker H
Carcinogenesis; 2012 Apr; 33(4):751-9. PubMed ID: 22301279
[TBL] [Abstract][Full Text] [Related]
4. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
5. Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer.
Capo-chichi CD; Cai KQ; Smedberg J; Ganjei-Azar P; Godwin AK; Xu XX
Chin J Cancer; 2011 Jun; 30(6):415-25. PubMed ID: 21627864
[TBL] [Abstract][Full Text] [Related]
6. Global loss of a nuclear lamina component, lamin A/C, and LINC complex components SUN1, SUN2, and nesprin-2 in breast cancer.
Matsumoto A; Hieda M; Yokoyama Y; Nishioka Y; Yoshidome K; Tsujimoto M; Matsuura N
Cancer Med; 2015 Oct; 4(10):1547-57. PubMed ID: 26175118
[TBL] [Abstract][Full Text] [Related]
7. The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression.
Bertacchini J; Beretti F; Cenni V; Guida M; Gibellini F; Mediani L; Marin O; Maraldi NM; de Pol A; Lattanzi G; Cocco L; Marmiroli S
FASEB J; 2013 Jun; 27(6):2145-55. PubMed ID: 23430973
[TBL] [Abstract][Full Text] [Related]
8. A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward.
Marmiroli S; Bertacchini J; Beretti F; Cenni V; Guida M; De Pol A; Maraldi NM; Lattanzi G
J Cell Physiol; 2009 Sep; 220(3):553-61. PubMed ID: 19479937
[TBL] [Abstract][Full Text] [Related]
9. Increased Lamin B1 Levels Promote Cell Migration by Altering Perinuclear Actin Organization.
Fracchia A; Asraf T; Salmon-Divon M; Gerlitz G
Cells; 2020 Sep; 9(10):. PubMed ID: 32987785
[TBL] [Abstract][Full Text] [Related]
10. Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion.
Ye Y; Tang X; Sun Z; Chen S
Oncotarget; 2016 Apr; 7(14):17854-69. PubMed ID: 26895380
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
[TBL] [Abstract][Full Text] [Related]
12. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2.
Nitta RT; Smith CL; Kennedy BK
PLoS One; 2007 Sep; 2(9):e963. PubMed ID: 17896003
[TBL] [Abstract][Full Text] [Related]
13. Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
Hong BS; Ryu HS; Kim N; Kim J; Lee E; Moon H; Kim KH; Jin MS; Kwon NH; Kim S; Kim D; Chung DH; Jeong K; Kim K; Kim KY; Lee HB; Han W; Yun J; Kim JI; Noh DY; Moon HG
Cancer Res; 2019 Apr; 79(7):1520-1534. PubMed ID: 30737233
[TBL] [Abstract][Full Text] [Related]
14. Lamin A/C is a risk biomarker in colorectal cancer.
Willis ND; Cox TR; Rahman-Casañs SF; Smits K; Przyborski SA; van den Brandt P; van Engeland M; Weijenberg M; Wilson RG; de Bruïne A; Hutchison CJ
PLoS One; 2008 Aug; 3(8):e2988. PubMed ID: 18714339
[TBL] [Abstract][Full Text] [Related]
15. Expression of Lamin A/C in early-stage breast cancer and its prognostic value.
Alhudiri IM; Nolan CC; Ellis IO; Elzagheid A; Rakha EA; Green AR; Chapman CJ
Breast Cancer Res Treat; 2019 Apr; 174(3):661-668. PubMed ID: 30610489
[TBL] [Abstract][Full Text] [Related]
16. Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer.
Rahmani F; Ferns GA; Talebian S; Nourbakhsh M; Avan A; Shahidsales S
Gene; 2020 May; 737():144459. PubMed ID: 32045660
[TBL] [Abstract][Full Text] [Related]
17. Myopathic lamin mutations cause reductive stress and activate the nrf2/keap-1 pathway.
Dialynas G; Shrestha OK; Ponce JM; Zwerger M; Thiemann DA; Young GH; Moore SA; Yu L; Lammerding J; Wallrath LL
PLoS Genet; 2015 May; 11(5):e1005231. PubMed ID: 25996830
[TBL] [Abstract][Full Text] [Related]
18. Prelamin A and lamin A appear to be dispensable in the nuclear lamina.
Fong LG; Ng JK; Lammerding J; Vickers TA; Meta M; Coté N; Gavino B; Qiao X; Chang SY; Young SR; Yang SH; Stewart CL; Lee RT; Bennett CF; Bergo MO; Young SG
J Clin Invest; 2006 Mar; 116(3):743-52. PubMed ID: 16511604
[TBL] [Abstract][Full Text] [Related]
19. Altered Lamin A/C splice variant expression as a possible diagnostic marker in breast cancer.
Aljada A; Doria J; Saleh AM; Al-Matar SH; AlGabbani S; Shamsa HB; Al-Bawab A; Ahmed AA
Cell Oncol (Dordr); 2016 Apr; 39(2):161-74. PubMed ID: 26732077
[TBL] [Abstract][Full Text] [Related]
20. Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway.
Fan L; Zhang Y; Zhou Q; Liu Y; Gong B; Lü J; Zhu H; Zhu G; Xu Y; Huang G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30401729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
